Blog

Protocols, news, and product updates.

• The 2026 peptide outlook — what's coming

  Retatrutide hitting Phase 3 results, cagrilintide approval window, klotho moving toward humans. Where the field is heading this year.

  May 27, 2026 · research · retatrutide · klotho · humanin · longevity

• 5 common mistakes when starting a GLP-1 protocol

  The errors that turn first-month GLP-1 users off the protocol entirely. Most are preventable in 60 seconds.

  May 26, 2026 · semaglutide · tirzepatide · glp-1 · protocols

• Cagrilintide vs CagriSema — which one to pick

  Cagrilintide is the amylin half of CagriSema. When does the combo win, when is the standalone enough?

  May 25, 2026 · cagrilintide · cagrisema · glp-1 · fat-loss

• BPC-157 reconstitution — 4 common mistakes

  Most BPC-157 dosing errors happen at reconstitution. Here's what to watch for.

  May 24, 2026 · bpc-157 · reconstitution · protocols

• How we picked the 31 peptides in Peptora v1

  The selection criteria behind our launch library — and what didn't make the cut.

  May 23, 2026 · product · methodology

• Welcome to Peptora

  Why we built a peptide reference app — and what's coming next.

  May 22, 2026 · announcement · product